TrialSite News Research Contributes to Indian Physicians Call for Ivermectin-based Research Targeting COVID-19

TrialSite News Research Contributes to Indian Physicians Call for Ivermectin-based Research Targeting COVID-19

According to a brief mention in the Times of India, a recent white paper discussing the potential of Ivermectin as a treatment for SARS-CoV-2 has been embraced by the World Health Organization (WHO). Published in the Indian Journal of Tuberculosis Elsevier, the recent article suggests WHO has referred to this literature. TrialSite News’ research efforts are recognized and cited, something that other journalists and media are failing to do too often. Indian physicians, including Dr. VK Aroroa (Delhi), Dr. D Behera (Chandigarh), Dr. Agam Vora (Mumbai), Dr. T Mohan Kumar (Coimbatore), Dr. Narayana Pradeep and Prof Surya Kant authored, “White Paper on Ivermectin as a Potential Therapy for COVID-19” in July, 2020.

The gathering of senior doctors with extensive clinical experience met on July 19, 2020 under the aegis of Academy of Advanced Medical Education. With Ivermectin as a focal point of discussion, the panel reviewed the growing off-label use of the common anti-parasitic drug targeting COVID-19. The group concluded that Ivermectin can be a potential molecule for prophylaxis and treatment of people infected with Coronavirus, due to its anti-viral properties, coupled with effect...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee